Details of the Drug

General Information of Drug (ID: DMMPFZO)

Drug Name
IC9.GD2.CAR.IL-15 T-cells
Indication
Disease Entry ICD 11 Status REF
Neuroblastoma 2D11.2 Phase 1 [1]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D0H0LK

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ganglioside GD2 (GD2) TT80ARU NOUNIPROTAC CAR-T-Cell-Therapy [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03721068) Phase I Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma